Feng Bi
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Oncology 50
- Colorectal Cancer Treatments and Studies 23
- Cancer Immunotherapy and Biomarkers 10
-
- Gastric Cancer Management and Outcomes 13
- Renal cell carcinoma treatment 6
- Co-authors
- Qiulin Tang (32 shared papers)Hongwei Xia (19 shared papers)Qiyong Gong (21 shared papers)Xiaoqi Huang (13 shared papers)Huanji Xu (13 shared papers)Su Lui (11 shared papers)Gongmin Zhu (3 shared papers)Lijiao Pei (2 shared papers)
- Journals
- Annals of Oncology (6 papers)癌症:英文版 (5 papers)Oncotarget (5 papers)Medical Oncology (4 papers)International Journal of Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Feng Bi
124 papers receiving 6k citations
Feng Bi's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 1.7k
- Cancer Research 714
- Hepatology 374
- Pulmonary and Respiratory Medicine 1.1k
- Psychiatry and Mental health 453
Countries citing papers authored by Feng Bi
This map shows the geographic impact of Feng Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Bi more than expected).
Fields of papers citing papers by Feng Bi
This network shows the impact of papers produced by Feng Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Bi. The network helps show where Feng Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 650 |
| 2 | The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021 Hit paper breakdown → | 2021 | 488 |
| 3 | Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer Hit paper breakdown → | 2021 | 329 |
| 4 | Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial Hit paper breakdown → | 2021 | 314 |
| 5 | Ferroptosis in the tumor microenvironment: perspectives for immunotherapy Hit paper breakdown → | 2021 | 249 |
| 6 | The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023 Hit paper breakdown → | 2023 | 224 |
| 7 | 2017 | 212 | |
| 8 | 2011 | 152 | |
| 9 | 2015 | 151 | |
| 10 | 2010 | 145 | |
| 11 | 2015 | 141 | |
| 12 | 2015 | 139 | |
| 13 | 2016 | 129 | |
| 14 | 2014 | 125 | |
| 15 | 2011 | 109 | |
| 16 | 2013 | 107 | |
| 17 | 2018 | 107 | |
| 18 | 2016 | 92 | |
| 19 | 2019 | 92 | |
| 20 | 2014 | 87 |
About Feng Bi
Feng Bi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Cell Biology, having authored 128 papers that have together received 6.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (23 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), MicroRNA in disease regulation (7 papers), Renal cell carcinoma treatment (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Functional Brain Connectivity Studies (5 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (714 citations), Hepatology (374 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Psychiatry and Mental health (453 citations). Feng Bi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qiulin Tang, Hongwei Xia, Qiyong Gong, Xiaoqi Huang, Huanji Xu, Su Lui, Gongmin Zhu, Lijiao Pei, Meng Qiu and Yuxian Bai. Their work appears in journals such as Annals of Oncology, 癌症:英文版, Oncotarget, Medical Oncology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.